Sunday, April 4, 2021

Serum Institute may seek permission for commercial sale of Covishield: Report

Serum Institute may seek permission for commercial sale of Covishield: Report SII might apply for marketing authorisation of the COVID-19 vaccine to the CDSCO by the end of April.

from Moneycontrol Business News https://ift.tt/2PAIg1V

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...